Loomis, Sayles & Company
ONXX

Loomis, Sayles & Company’s ONYX PHARMACEUTICALS INC ONXX Stock Holding History

Loomis, Sayles & Company’s Portfolio ONXX Stock Details ONXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-22,646
Closed -$1.97K – 788
2013
Q2 		$1.97K Buy
+22,646
New +$2.08M 0.01% 569

Other funds holding ONXX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
ACPU
Arrowgrass Capital Partners (US) Dover, Delaware $380M AUM 20.87% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Loomis, Sayles & Company's ONXX Position: Q3 2013 in Review

Loomis, Sayles & Company sold out of ONYX PHARMACEUTICALS INC (ONXX) in Q3 2013, closing a stake of 22,646 shares — an estimated $1.97K sold.

Loomis, Sayles & Company first reported a position in ONXX in Q2 2013 and held it in 1 quarter. The position peaked at $1.97K in Q2 2013. 258 funds tracked by Wall St. Rank hold ONXX as of Q3 2013.

  • Loomis, Sayles & Company reported no remaining ONYX PHARMACEUTICALS INC position as of Q3 2013 after selling out during the quarter.
  • Loomis, Sayles & Company sold 22,646 ONYX PHARMACEUTICALS INC shares in Q3 2013, an estimated $1.97K.
  • Loomis, Sayles & Company first reported a position in ONYX PHARMACEUTICALS INC in Q2 2013 and held it in 1 quarter.
  • Loomis, Sayles & Company's ONYX PHARMACEUTICALS INC position peaked at $1.97K in Q2 2013.
  • 258 funds tracked by Wall St. Rank held ONYX PHARMACEUTICALS INC as of Q3 2013.

Based on Loomis, Sayles & Company's 13F filing for Q3 2013, filed 14 Nov 2013.